approval · primary record
BENDAMUSTINE HYDROCHLORIDE
FDA · NDA · 2026-09-25
| Agency | FDA |
|---|---|
| Submission type | NDA |
| Action date | 2026-09-25 |
| Brand | GOBARDEN |
| Sponsor | AVYXA HOLDINGS |
| Route | INTRAVENOUS |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T10:38:34.769Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:BENDAMUSTINE HYDROCHLORIDE:2026-09-25
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- bendamustine hydrochloride · trial
- Bendamustine Hydrochloride · compound